Cysticercosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(8 intermediate revisions by 5 users not shown)
Line 10: Line 10:
{{Cysticercosis}}
{{Cysticercosis}}


{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; {{AE}} {{CZ}},{{AY}}


{{SK}}  Taenia solium infection, cysticerciasis, Larval taeniasis, Larval teniasis
{{SK}}  Taenia solium infection, Cysticerciasis, Larval taeniasis, Larval teniasis.


==[[cysticercosis overview|Overview]]==
==[[cysticercosis overview|Overview]]==
Line 34: Line 34:
==[[cysticercosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[cysticercosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==[[Diagnosis]]==
==Diagnosis==
===CT===
[[cysticercosis history and symptoms|History and Symptoms]] | [[cysticercosis physical examination|Physical Examination]] | [[cysticercosis electrocardiogram|Electrocardiogram]] | [[cysticercosis laboratory findings|Laboratory Findings]] | [[cysticercosis x ray|X-Ray Findings]] | [[cysticercosis echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[cysticercosis CT scan|CT-Scan Findings]] | [[cysticercosis MRI|MRI Findings]] | [[cysticercosis other diagnostic studies|Other Diagnostic Studies]] | [[cysticercosis other imaging findings|Other Imaging Findings]]
[[Computerized tomography]] (CT) is superior to [[magnetic resonance imaging]] (MRI) for demonstrating small [[calcification]]s. However, MRI shows cysts in some locations (cerebral convexity, ventricular ependyma) better than CT, is more sensitive than CT to demonstrate surrounding [[cerebral edema|edema]], and may show internal changes indicating the death of cysticerci.
 
In recent years, the use of CT and MRI has permitted identification of neurocysticercosis cases with a benign course that would not have been detected previously.
 
[[cysticercosis history and symptoms|History and Symptoms]] | [[cysticercosis physical examination|Physical Examination]] | [[cysticercosis laboratory findings|Laboratory Findings]] | [[cysticercosis CT|CT]] | [[cysticercosis MRI|MRI]] | [[cysticercosis other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
 
[[cysticercosis medical therapy|Medical Therapy]] | [[cysticercosis surgery|Surgery]] | [[cysticercosis primary prevention|Primary Prevention]] | [[cysticercosis secondary prevention|Secondary Prevention]] | [[cysticercosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[cysticercosis future or investigational therapies|Future or Investigational Therapies]]
[[cysticercosis medical therapy|Medical Therapy]] | [[cysticercosis surgery|Surgery]] | [[cysticercosis primary prevention|Primary Prevention]]
 
===Antimicrobial therapy===
 
:* '''Neurocysticercosis treatment'''
::* 1. '''Parenchymal neurocysticercosis'''
:::* 1.1 '''Single lesions'''<ref name="pmid12364377">{{cite journal| author=García HH, Evans CA, Nash TE, Takayanagui OM, White AC, Botero D et al.| title=Current consensus guidelines for treatment of neurocysticercosis. | journal=Clin Microbiol Rev | year= 2002 | volume= 15 | issue= 4 | pages= 747-56 | pmid=12364377 | doi= | pmc=PMC126865 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12364377  }} </ref>
::::* Preferred regimen:  [[Albendazole]] 15 mg/kg/day PO bid for 3-8 days {{and}} [[Prednisone]] 1 mg/kg/day PO qid for 8-10 days followed by a taper
:::* 1.2  '''Multiple cysts'''
::::* Preferred regimen: [[Albendazole]] 15 mg/kg/day PO bid for 8-15 days and high-dose steroids
::::* Preferred regimen: [[Praziquantel]] 50 mg/kg/day PO tid {{and}} [[Albendazole]] 15 mg/kg/day PO bid
:::* 1.3 '''Cysticercal encephalitis''' <ref name="pmid12364377">{{cite journal| author=García HH, Evans CA, Nash TE, Takayanagui OM, White AC, Botero D et al.| title=Current consensus guidelines for treatment of neurocysticercosis. | journal=Clin Microbiol Rev | year= 2002 | volume= 15 | issue= 4 | pages= 747-56 | pmid=12364377 | doi= | pmc=PMC126865 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12364377  }} </ref>
::::* Cysticercal encephalitis (diffuse cerebral edema associated with multiple inflamed cysticerci) is a contraindication for antiparasitic therapy, since enhanced parasite killing can exacerbate host inflammatory response and lead to diffuse cerebral edema and potential transtentorial herniation. Most cases of cysticercal encephalitis improve with corticosteroid therapy
:::* 1.4 '''Calcified cysts '''
::::* Radiographic evidence of parenchymal calcifications is a significant risk factor for recurrent seizure activity; these lesions are present in about 10 percent of individuals in regions where neurocysticercosis is endemic. Seizures in these patients should be treated with antiepileptic therapy.
::* 2. '''Extraparenchymal NCC'''
:::* 2.1 '''Subarachnoid cysts'''
::::* Preferred regimen: [[Albendazole]] 15 mg/kg/day PO bid  for  28 days {{and}} ([[Prednisone]] up to 60 mg/day PO {{or}} [[Dexamethasone]] (up to 24 mg/day)) along with the antiparasitic therapy. The dose can often be tapered after a few weeks. However, in cases for which more prolonged steroid therapy is required, methotrexate can be used as a steroid-sparing agent
:::*  2.2 '''Giant cysts'''
::::* Giant cysticerci are usually accompanied by cerebral edema and mass effect, which should be managed with high-dose corticosteroids (with or without mannitol).
:::* 2.3 ''' Intraventricular cysts'''
::::* Emergent management with CSF diversion via a ventriculostomy or placement of a ventriculo-peritoneal shunt
::::* Treatment of residual hydrocephalus may be managed with endoscopic foraminotomy and endoscopic third ventriculostomy; this approach may also allow debulking of cisternal cysticerci
:::* 2.4 ''' Ocular cysticercosis'''
::::* Surgical excision is warranted in the setting of intraocular cysts
::::* Cysticercal involvement of the extraocular muscles should be managed with albendazole and corticosteroids.
:::* 2.5 '''Spinal cysticercosis'''
::::* Medical therapy with corticosteroids and anti parasitic drugs
 
 
==References==
{{reflist|2}}


==Case Studies==
==Case Studies==
[[cysticercosis case study one|Case #1]]
[[cysticercosis case study one|Case #1]]
'''
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Dermatology]]

Latest revision as of 21:11, 29 July 2020

Template:DiseaseDisorder infobox

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Taenia solium.

For patient information click here

Cysticercosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cysticercosis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Cysticercosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cysticercosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cysticercosis

CDC on Cysticercosis

Cysticercosis in the news

Blogs on Cysticercosis

Directions to Hospitals Treating Cysticercosis

Risk calculators and risk factors for Cysticercosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2],Ahmed Younes M.B.B.CH [3]

Synonyms and keywords: Taenia solium infection, Cysticerciasis, Larval taeniasis, Larval teniasis.

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cysticercosis From other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WikiDoc Sources